RFP - supply of a CDK4/CDK6 inhibitor for the treatment of HR-positive, HER2-negative locally advanced or metastatic breast cancer

Medicines

RFP Closed

PHARMAC invites proposals for the supply of a CDK4/CDK6 inhibitor for the treatment of HR-positive, HER2-negative locally advanced or metastatic breast cancer in New Zealand.

This request for proposals (RFP) document incorporates the following schedules:

Full text of RFP - supply of a CDK4/CDK6 inhibitor [PDF, 118 KB]

PHARMAC's standard terms and conditions [PDF, 79 KB]

If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no later than 5pm NZT Monday 14 October 2019 - RFx ID 21504218.

We encourage suppliers to register with GETS and subscribe to this RFP. If you have any questions about this RFP, please post these on GETS (www.gets.govt.nz(external link)). 

We look forward to receiving your proposal.